Clinical Research Directory
Browse clinical research sites, groups, and studies.
Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia
Sponsor: Centre Hospitalier Universitaire de Nīmes
Summary
Per Oral Endoscopic Myotomy (POEM) is a treatment of choice for achalasia with an excellent safety and efficacy profile. There is a high rate of esophagitis related to gastroesophageal reflux following this procedure. There is no recommendation on the prescription of protein pump inhibitors (PPI) after the procedure and no study has studied the benefit of systematic prescription of PPI after POEM for achalasia. The study authors hypothesize that routine PPI prescribing post-POEM for 12 months would reduce the rate of esophageal acid exposure compared to a symptom-based prescribing strategy.
Official title: Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia. Randomized Open-label Clinical Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
132
Start Date
2023-06-01
Completion Date
2028-02
Last Updated
2026-02-10
Healthy Volunteers
No
Conditions
Interventions
Protein pump inhibitor therapy systematically
Lansoprazole 30mg once per day
Locations (4)
AP-HM
Marseille, France
CHU de Montpellier
Montpellier, France
Clinique mutualiste Beausoleil
Montpellier, France
CHU de Nîmes
Nîmes, France